EISENBACH-SCHWARTZ MICHAL has a total of 16 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ECONUGENICS INC, MCLAURIN JOANNE and IPSEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Eisenbach-Schwartz Michal | 16 |
#2 | Kipnis Jonathan | 8 |
#3 | Butovsky Oleg | 5 |
#4 | Yoles Ester | 3 |
#5 | Fulga Valentin | 2 |
#6 | Bakalash Sharon | 2 |
#7 | Ron Noga | 2 |
#8 | Arnon Ruth | 2 |
#9 | Aharoni Rina | 2 |
#10 | Ziv Yaniv | 2 |
Publication | Filing date | Title |
---|---|---|
WO2005055920A2 | Compositions and methods for treatment of psychiatric disorders | |
US2008085269A1 | Vaccine And Method For Treatment Of Neurodegenerative Diseases | |
WO2004103262A2 | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells | |
WO2004103263A2 | Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases |